If you liked this article you might like

4 Blue-Chip Health-Care Picks on Sale (and the Portfolio Is Up 163% Since 2006)
Impax Searches for a New CEO
DOJ Files Charges in Generic Drug Price-Fixing Investigation
Sun's Taro Unit Names New CEO Amid Generics Investigation